Isoniazid activity is terminated by bacterial persistence [2]
dc.contributor.author | Mitchison D.A. | |
dc.contributor.author | Jindani A. | |
dc.contributor.author | Davies G.R. | |
dc.contributor.author | Sirgel F. | |
dc.date.accessioned | 2011-05-15T16:03:33Z | |
dc.date.available | 2011-05-15T16:03:33Z | |
dc.date.issued | 2007 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Letter | |
dc.identifier.citation | Journal of Infectious Diseases | |
dc.identifier.citation | 195 | |
dc.identifier.citation | 12 | |
dc.identifier.issn | 221899 | |
dc.identifier.other | 10.1086/518046 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/12675 | |
dc.subject | isoniazid | |
dc.subject | antibacterial activity | |
dc.subject | antibiotic resistance | |
dc.subject | bacterial growth | |
dc.subject | bactericidal activity | |
dc.subject | bacterium culture | |
dc.subject | clinical feature | |
dc.subject | human | |
dc.subject | in vitro study | |
dc.subject | letter | |
dc.subject | monotherapy | |
dc.subject | persistent infection | |
dc.subject | pharmacodynamics | |
dc.subject | phenotype | |
dc.subject | priority journal | |
dc.subject | Antitubercular Agents | |
dc.subject | Drug Resistance, Bacterial | |
dc.subject | Humans | |
dc.subject | Isoniazid | |
dc.subject | Models, Biological | |
dc.subject | Mycobacterium tuberculosis | |
dc.subject | Tuberculosis | |
dc.title | Isoniazid activity is terminated by bacterial persistence [2] | |
dc.type | Letter |